AXT-1003

· Axter Therapeutics (Beijing) Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AXT-1003, covering 2024-08-01 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of AXT-1003 in Subjects With Advanced Malignant Tumors. [Phase 1]